TSSC1 anticorps (C-Term)

N° du produit ABIN5537652

Détail du produit anti-TSSC1 anticorps

Antigène: TSSC1 (Tumor Suppressing Subtransferable Candidate 1 (TSSC1))

Épitope: AA 319-348, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TSSC1 est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This TSSC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 319-348 amino acids from the C-terminal region of human TSSC1.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.38 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur TSSC1

Antigène: TSSC1 (Tumor Suppressing Subtransferable Candidate 1 (TSSC1))

Autre désignation: TSSC1 (TSSC1 Produits)

Synonymes: anticorps zgc:101720, anticorps TSSC1, anticorps tssc1, anticorps D12Ertd604e, anticorps tumor suppressing subtransferable candidate 1, anticorps EARP complex and GARP complex interacting protein 1, anticorps EARP complex and GARP complex interacting protein 1 L homeolog, anticorps TSSC1, anticorps eipr1, anticorps EIPR1, anticorps Eipr1, anticorps Tssc1, anticorps eipr1.L

Sujet: This gene has been reported in PMID 9403053 as one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. Alignment of this gene to genomic sequence data suggests that this gene resides on chromosome 2 rather than chromosome 11. [provided by RefSeq].

Poids moléculaire: 44 kDa

ID gène: 7260

UniProt: Q53HC9